Subscribe

Biocompounding

Biocompounding

Align Technology (ALGN): Modernizing dentistry with 3D printing and digitalization

Align Technology (ALGN): Modernizing dentistry with 3D printing and digitalization

Introduction Align Technology (NASDAQ: ALGN), founded in 1997 by visionaries Zia Chishti and Kelsey Wirth in Santa Clara, California, has dramatically transformed the orthodontics landscape with its groundbreaking Invisalign system. Their innovative approach combined cutting-edge digital imaging and 3D printing technology, offering a discreet and effective alternative to traditional metal

West Pharmaceuticals (WST) - enabling pharmaceutical companies to get their products to their customers

West Pharmaceuticals (WST) - enabling pharmaceutical companies to get their products to their customers

Introduction West Pharmaceutical Services, Inc., founded in 1923 by Herman O. West, stands as a pioneering force in the global healthcare industry, with a rich history spanning nearly a century. Headquartered in Exton, Pennsylvania, West Pharma has evolved into a key player in providing innovative packaging components and delivery systems

An Overview of ADC Therapeutic's in Oncology

An Overview of ADC Therapeutic's in Oncology

Part 1: Exploring ADC functionality and an overview of FDA-approved oncology treatments As part of the expansion from our “Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy” article, we have previously described how Chimeric Antigen Receptor (CAR)-T cell therapies are used to treat various types of

From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions

From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions

Intuitive Surgical

Crucial Metrics to Monitor for Intuitive Surgical and a Valuation Analysis

A few months ago, we conducted an in-depth analysis of Intuitive Surgical (ISRG) and performed a preliminary valuation. In our most recent research, we dedicated time to a more comprehensive examination of Intuitive Surgical's growth prospects and financials. Our goal was to identify the essential factors that shape

Ascendis Pharma (ASND): Redefining Drug Delivery with TransCon

Introduction Ascendis Pharma is a biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs. The company was founded in 2007 and is headquartered in Copenhagen, Denmark, with offices in the United States. The

Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth

Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth

Introduction Halozyme Therapeutics is a biotechnology company that was co-founded in 1998 by Dr. Gregory Frost and subsequently listed in 2014. Halozyme’s focus was on oncology therapies and drug delivery technologies based on its proprietary recombinant human hyaluronidase enzyme, rHuPH20, but following the failure of its oncology drug, the